No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RPHM240517C2500
- 0.05
- 0.000.00%
15min DelayClose May 8 14:34 ET
0.05High0.05Low
0.05Open0.05Pre Close1 Volume1.47K Open Interest2.50Strike Price5.00Turnover193.64%IV39.34%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type0.1889Delta0.4910Gamma36.60Leverage Ratio-0.0085Theta0.0001Rho6.91Eff Leverage0.0008Vega
Intraday
- 5D
- 1D
News
Reneo Pharmaceuticals | 10-Q: Quarterly report
Express News | Reneo Pharmaceuticals Inc - Retained an Independent Financial Advisor to Initiate a Formal Process to Evaluate Potential Strategic Alternatives
Express News | Reneo Pharmaceuticals Q1 EPS USD -0.25
Express News | Reneo Pharmaceuticals Q1 Net Income USD -8.4 Million
Express News | Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Target